Survival benefits of neoadjuvant chemo(radio)therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta-analysis.

World J Surg Oncol · 2019 · PMC6937851 · PMID 31892339

Europe PMC DOI

hedged sentence

0.1370

closest p · 2.7× alpha

0.1370

boldest claim

The sentences

did not reach statistical significanceP = 0.137not close (p > 0.1)

Moreover, RPC patients who underwent NAC(R)T had higher DFS and lower recurrence rate than those who underwent SF, although advantages did not reach statistical significance (DFS: HR = 0.80, P = 0.137; recurrence rate: OR = 0.77, P = 0.131).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.